148 related articles for article (PubMed ID: 9560111)
21. [Monitoring of intraperitoneal administration of vancomycin in patients on continuous ambulatory peritoneal dialysis].
Montañés-Pauls B; Alós Almiñana M; Casabó Alós VG; García Pérez H
Farm Hosp; 2012; 36(5):328-35. PubMed ID: 22264836
[TBL] [Abstract][Full Text] [Related]
22. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
Mulhern JG; Braden GL; O'Shea MH; Madden RL; Lipkowitz GS; Germain MJ
Am J Kidney Dis; 1995 Apr; 25(4):611-5. PubMed ID: 7702059
[TBL] [Abstract][Full Text] [Related]
23. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
[TBL] [Abstract][Full Text] [Related]
24. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
Lye WC; Wong PL; van der Straaten JC; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():179-81. PubMed ID: 8534699
[TBL] [Abstract][Full Text] [Related]
25. Hearing thresholds in CAPD patients.
Morton LP; Reynolds L; Zent R; Rayner BL
Adv Perit Dial; 1992; 8():150-2. PubMed ID: 1361774
[TBL] [Abstract][Full Text] [Related]
26. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gray HH; Goulding S; Eykyn SJ
Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
[TBL] [Abstract][Full Text] [Related]
27. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin.
Chadwick DH; Agarwal S; Vora BJ; Hair M; McKewan A; Gokal R
J Nephrol; 1999; 12(5):318-21. PubMed ID: 10630696
[TBL] [Abstract][Full Text] [Related]
28. Comparison of intraperitoneal administration of two preparations of vancomycin in causing chemical peritonitis.
Wang AY; Li PK; Lai KN
Perit Dial Int; 1996; 16(2):172-4. PubMed ID: 9147552
[No Abstract] [Full Text] [Related]
29. Absorption of intraperitoneal antibiotics.
Morse GD; Apicella MA; Walshe JJ
Drug Intell Clin Pharm; 1988 Jan; 22(1):58-61. PubMed ID: 3349922
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin ototoxicity in patients with normal renal function.
Mellor JA; Kingdom J; Cafferkey M; Keane C
Br J Audiol; 1984 Aug; 18(3):179-80. PubMed ID: 6487853
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
Whitby M; Edwards R; Aston E; Finch RG
J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
[TBL] [Abstract][Full Text] [Related]
32. Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
Vas SI
Perit Dial Int; 1993; 13 Suppl 2():S355-6. PubMed ID: 8399610
[TBL] [Abstract][Full Text] [Related]
33. [Ototoxicity of locally administered aminoglycoside antibiotics].
Heidemüller B
Laryngorhinootologie; 1994 Jun; 73(6):331-7. PubMed ID: 8060454
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.
Blowey DL; Warady BA; Abdel-Rahman S; Frye RF; Manley HJ
Perit Dial Int; 2007; 27(1):79-85. PubMed ID: 17179516
[TBL] [Abstract][Full Text] [Related]
35. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gucek A; Bren AF; Hergouth V; Lindic J
Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
[TBL] [Abstract][Full Text] [Related]
36. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.
Szeto CC; Chow KM; Leung CB; Wong TY; Wu AK; Wang AY; Lui SF; Li PK
Kidney Int; 2001 Jun; 59(6):2309-15. PubMed ID: 11380835
[TBL] [Abstract][Full Text] [Related]
37. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
Neal D; Bailie GR
Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
[TBL] [Abstract][Full Text] [Related]
38. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
[TBL] [Abstract][Full Text] [Related]
40. Severe eosinophilic peritonitis caused by intraperitoneal vancomycin administration.
Hsu CY; Lee DJ; Lin SH
Clin Nephrol; 2021 Sep; 96(3):184-187. PubMed ID: 34042582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
